<DOC>
	<DOCNO>NCT01548118</DOCNO>
	<brief_summary>This study evaluate safety novel recombinant human papillomavirus bivalent ( type 16 18 ) vaccine ( Yeast ) different dose healthy female 9-45 year age enrollment .</brief_summary>
	<brief_title>Evaluate Safety Recombinant Human Papillomavirus Bivalent ( Types 16 18 ) Vaccine ( Yeast ) Healthy Females</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum phosphate</mesh_term>
	<criteria>Healthy female , include , 9 45 year age time first vaccination Provide legal identification sake recruitment . Be able understand sign inform consent prior enrollment ( For subject legal age consent , informed consent must sign parent ( ) /legal guardian ( ) addition ) . Subject must pregnant enrollment agree use adequate contraceptive precaution within 7 month . History cervical cancer History severe allergic reaction require medical intervention ( oral throat swelling , difficulty breathing , hypotension shock ) History allergic vaccine , ingredient vaccine . History epilepsy , seizures convulsion , family history mental illness Subjects immunocompromised diagnosed suffering congenital acquire immunodeficiency , HIV infection , lymphoma , leukemia , systemic lupus erythematosus ( SLE ) , rheumatoid arthritis , juvenile rheumatoid arthritis inflammation ( JRA ) , inflammatory bowel disease autoimmune disease , administration immunosuppressant six month prior first vaccine dose . History asthma , thyroidectomy , angioneurotic edema , diabetes malignant Asplenia , functional asplenia , circumstance result asplenia splenectomy Medical diagnosis coagulation abnormality ( eg , clot factor deficiency , coagulation disorder , platelet anomaly ) obvious bruise coagulation disorder Acute disease chronic disease acute exacerbation 7 day prior vaccination Administration immunoglobulins and/or blood product within 3 month , administration live attenuate vaccine within 28 day , administration subunit inactivate vaccine within 14 day . Fever axillary temperature &gt; 37.0 Â°C vaccination During menstrual period , breastfeeding , pregnancy ( pregnancy test positive ) , plan pregnant within 7 month History hypertension , physical examination systolic blood pressure &gt; 150mmHg and/or diastolic blood pressure &gt; 100mmHg Abnormal laboratory test parameter Any clinical significant disease finding study screening , opinion Investigator may interfere study</criteria>
	<gender>Female</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Human papillomavirus</keyword>
	<keyword>vaccine</keyword>
	<keyword>cervical infection</keyword>
	<keyword>cervical cancer</keyword>
</DOC>